Results 71 to 80 of about 14,990 (249)

Another rare presentation of allergic bronchopulmonary aspergillosis

open access: yesMonaldi Archives for Chest Disease, 2021
Mediastinal lymphadenopathy is often associated with tuberculosis, especially in a high burden country like India. We present a case of an asymptomatic female, who had mediastinal lymphadenopathy and middle lobe collapse, both of which pointed towards a ...
Komaldeep Kaur   +4 more
doaj   +1 more source

Immunogenetics of invasive aspergillosis [PDF]

open access: yes, 2017
Invasive aspergillosis is one of the most important infections in hematopoietic stem cell transplant recipients, with an incidence rate of 5-15% and an associated mortality of 30-60%. It remains unclear why certain patients develop invasive aspergillosis
Bochud, Pierre-Yves   +2 more
core  

Beyond Cystic Fibrosis: Recognising Shwachman‐Diamond Syndrome in the Respiratory Clinic

open access: yesRespirology Case Reports, Volume 13, Issue 12, December 2025.
Our case shows how SDS can mimic CF (borderline sweat electrolytes, recurrent lower respiratory infections, pancreatic insufficiency) but diverge in trajectory and management. Over 42 years, our patient demonstrated: (1) recurrent infections, (2) persistent pancreatic insufficiency and (3) intermittent neutropenia.
Freda Yang   +3 more
wiley   +1 more source

Pediatric Pulmonary and Thoracic Aspergillosis

open access: yesSiriraj Medical Journal, 2020
Aspergillus infection can cause significant disease in an immunocompromised host and lungs are the most common site of infection. Various forms of aspergillus involving lung parenchyma have been described including aspergilloma, allergic bronchopulmonary
Preeyacha Pacharn   +3 more
doaj  

Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis

open access: yesRespirology Case Reports, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is common in cystic fibrosis (CF). Treatment is challenging and the relapse rate is high. Standard therapy is oral steroids and antifungals.
M. Boyle   +5 more
semanticscholar   +1 more source

Case Report: Allergic Bronchopulmonary Aspergillosis Revealing Asthma

open access: yesFrontiers in Immunology, 2021
Allergic bronchopulmonary aspergillosis (ABPA) is an immunological pulmonary disorder caused by hypersensitivity to Aspergillus which colonizes the airways of patients with asthma and cystic fibrosis. Its diagnosis could be difficult in some cases due to
Houda Snen   +17 more
doaj   +1 more source

Post endodontic Aspergillosis in an immunocompetent individual [PDF]

open access: yes, 2015
Non-invasive aspergillosis in immunocompetent individuals subsequent to post endodontic treatment can involve the maxillary antrum. An early and accurate diagnosis will aid in prompt and effective treatment. A 35 year old female patient reported with a
Gupta, Shalini   +4 more
core   +2 more sources

Molecular allergen sensitization of Aspergillus fumigatus between allergic bronchopulmonary aspergillosis and A fumigatus‐sensitized asthma in Guangzhou, Southern China

open access: yesJournal of clinical laboratory analysis (Print), 2020
Few studies have assessed the sensitization of mycotic allergens and Aspergillus fumigatus molecular allergens. This study aimed to investigate the relationships of A fumigatus components and mycotic allergens in allergic bronchopulmonary aspergillosis ...
W. Luo   +7 more
semanticscholar   +1 more source

Allergic Bronchopulmonary Aspergillosis Unmasked: Case Series of Varied Pulmonary Presentations [PDF]

open access: yesIndian Journal of Respiratory Care
Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to the fungus Aspergillus fumigatus, primarily affecting individuals with asthma or cystic fibrosis (CF).
Anand R   +3 more
doaj   +1 more source

Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis [PDF]

open access: yes, 2018
An increasing incidence of allergic bronchopulmonary aspergillosis (ABPA) as a complication in patients with cystic fibrosis (CF) is reported. The objective of this retrospective case-control study was to assess potential risk factors for ABPA and for ...
Ammann, Roland   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy